Need of beta 3 agonist in today’s world as oral hypoglycaemic and antiobesity

Journal Title: International Journal of Medical and Dental Sciences - Year 2018, Vol 7, Issue 1

Abstract

no abstract

Authors and Affiliations

Keywords

Related Articles

Comparison of the Routine Papanicolaou Staining Technique with the Rapid, Economic, Acetic Acid, Papanicolaou (REAP) Technique

Background: The universal stain for oral cytological screening for precancer and cancer of oral cavity is Papanicolaou stain which has been used in different laboratories with many modifications. Objectives: To assess t...

Effect of Promotional literature on the prescribing habits of practitioners

Pharmaceutical companies are the manufacturing units of drugs, with established conformity for dispersal into the public. To increase their sales and hence, their shareholder value, these corporations need to make their...

Various Obturation Methods Used in Deciduous Teeth

Pulpectomy is one of the treatment options used to maintain primary teeth with radicular pulpal tissue inflammation or that have become nonvital, until normal exfoliation. The primary goal of this procedure is to maintai...

Probiotics in health and disease

Importance of normal microbial flora in human bodies to maintain optimal health cannot be under estimated. Probiotics or live microorganisms confer health benefit in various diseases. Thus potential of probiotics to main...

Low molecular weight heparin induced bullous hemorrhagic dermatosis

Heparin-induced bullous hemorrhagic dermatosis is a rare, recently described side-effect of subcutaneous heparin injection. We present a case of a male patient with a bullous hemorrhagic eruption following the administra...

Download PDF file
  • EP ID EP448658
  • DOI 10.18311/ijmds/2018/18903
  • Views 85
  • Downloads 0

How To Cite

(2018). Need of beta 3 agonist in today’s world as oral hypoglycaemic and antiobesity. International Journal of Medical and Dental Sciences, 7(1), 1574-1575. https://europub.co.uk/articles/-A-448658